PoemStone: I see that (the 3-yaer chart) as a distinctive formation subject to sudden shifts in range; there is firm support at the current levels, and, as seen late in 2012, from a fractal standpoint, there is also a likelihood of moving up quickly in response to any major news. Considering the unique IP and the quality of management, I see a great deal of upside and opened a position today. Insiders hold a good solid position, too, bringing an element of coherence.

I find a stimulating degree of confirmation too in the Dec. 23rd PR, which sets off some strongly positive vibes. SeeThru may have worked well:

Dec 23, 2014 (ACCESSWIRE via COMTEX) -- New York, NY / ACCESSWIRE / December 23, 2014 / SeeThruEquity, a leading independent equity research and corporate access firm focused on smallcap and microcap public companies, today announced that it has initiated coverage on Applied DNA Sciences, Inc. (NASDAQ: APDN) with a 12-month price target of $5.40. The report is available here: APDN Initiation Report. SeeThruEquity is an approved equity research contributor on Thomson First Call, Capital IQ, FactSet, and Zack's.

Compared with today's close, the target indicated by SeeThruEquity is
virtually a double on a 12-month view, but that could turn out to be conservative, timewise and rangewise. All IMHO, I need hardly say.